Cutting-Edge Advances in Anticancer Therapies: Insights from the Third Edition of the Special Issue "Novel Anticancer Strategies"
- PMID: 39861702
- PMCID: PMC11769241
- DOI: 10.3390/pharmaceutics17010054
Cutting-Edge Advances in Anticancer Therapies: Insights from the Third Edition of the Special Issue "Novel Anticancer Strategies"
Abstract
Cancer incidence and mortality continue to rise at an alarming rate worldwide, underscoring the urgent need for more effective therapeutic interventions [...].
Conflict of interest statement
The author declares no conflicts of interest.
Similar articles
-
Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy.Int J Pharm X. 2024 Dec 25;9:100314. doi: 10.1016/j.ijpx.2024.100314. eCollection 2025 Jun. Int J Pharm X. 2024. PMID: 39834843 Free PMC article. Review.
-
Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions.Front Oncol. 2024 Dec 5;14:1504139. doi: 10.3389/fonc.2024.1504139. eCollection 2024. Front Oncol. 2024. PMID: 39703856 Free PMC article. Review.
-
Natural Products/Bioactive Compounds as a Source of Anticancer Drugs.Cancers (Basel). 2022 Dec 15;14(24):6203. doi: 10.3390/cancers14246203. Cancers (Basel). 2022. PMID: 36551687 Free PMC article. Review.
-
Editorial Commentary on the Special Issue "Antioxidant Therapy for Cardiovascular Diseases"-Cutting-Edge Insights into Oxidative Stress and Antioxidant Therapy in Cardiovascular Health.Antioxidants (Basel). 2024 Aug 26;13(9):1034. doi: 10.3390/antiox13091034. Antioxidants (Basel). 2024. PMID: 39334693 Free PMC article.
-
Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?Front Oncol. 2024 Oct 23;14:1438040. doi: 10.3389/fonc.2024.1438040. eCollection 2024. Front Oncol. 2024. PMID: 39507759 Free PMC article. Review.
References
-
- Zhu L., Ma M., Zhang L., Wang S., Guo Y., Ling X., Lin H., Lai N., Lin S., Du L., et al. System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy. Pharmaceutics. 2023;15:810. doi: 10.3390/pharmaceutics15030810. - DOI - PMC - PubMed
-
- Brás A.R., Fernandes P., Moreira T., Morales-Sanfrutos J., Sabidó E., Antunes A.M.M., Valente A., Preto A. New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential. Pharmaceutics. 2023;15:1731. doi: 10.3390/pharmaceutics15061731. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources